Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E5555 in coronary artery disease
ACTRN12607000541404Phase 2Recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2 trial of atopaxar in coronary arteriosclerosis (4 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Major bleeding events. Started Aug 2007; status: recruiting.
02
Drugs
atopaxar
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ACTRN12607000541404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000541404.